|
市場調査レポート
商品コード
1729266
日本のバイオマーカー市場レポート：製品タイプ、疾患、用途、エンドユーザー、地域別、2025年～2033年Japan Biomarkers Market Report by Product, Type, Disease, Application, End User, and Region 2025-2033 |
||||||
カスタマイズ可能
|
|||||||
| 日本のバイオマーカー市場レポート：製品タイプ、疾患、用途、エンドユーザー、地域別、2025年～2033年 |
|
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 119 Pages
納期: 5～7営業日
|
- 全表示
- 概要
- 目次
日本のバイオマーカーの市場規模は2024年に40億米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに118億米ドルに達し、2025年から2033年にかけて11.7%の成長率（CAGR）を示すと予測しています。この市場は、慢性疾患の増加、バイオテクノロジーとゲノミクスの進展、個別化医療の動向、分析技術の継続的な向上、バイオマーカーの利点に関するヘルスケア専門家と患者の意識の高まりなど、いくつかの重要な要因によって牽引されています。
本レポートで扱う主な質問
- 日本のバイオマーカー市場はこれまでどのように推移し、今後どのように推移していくのか？
- COVID-19が日本のバイオマーカー市場に与えた影響は？
- 日本のバイオマーカー市場の製品別区分は？
- 日本のバイオマーカー市場のタイプ別区分は？
- 日本のバイオマーカー市場の疾患別内訳は？
- 日本のバイオマーカー市場の用途別区分は？
- 日本のバイオマーカー市場のエンドユーザー別の区分は？
- 日本のバイオマーカー市場のバリューチェーンにおける様々なステージとは？
- 日本のバイオマーカーの主な促進要因と課題は何か？
- 日本のバイオマーカー市場の構造と主要プレーヤーは？
- 日本のバイオマーカー市場における競合の程度は？
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査の目的
- ステークホルダー
- データソース
- 市場推定
- 調査手法
第3章 エグゼクティブサマリー
第4章 日本のバイオマーカー市場- イントロダクション
- 概要
- 市場力学
- 業界動向
- 競合情報
第5章 日本のバイオマーカー市場情勢
- 過去および現在の市場動向（2019～2024年）
- 市場予測（2025～2033年）
第6章 日本のバイオマーカー市場- 製品別の内訳
- 消耗品
- サービス
- ソフトウェア
第7章 日本のバイオマーカー市場- タイプ別の内訳
- 有効性バイオマーカー
- 安全性バイオマーカー
- 検証バイオマーカー
第8章 日本のバイオマーカー市場- 疾患別の内訳
- がん
- 心血管疾患
- 神経疾患
- 免疫疾患
- 腎疾患
- その他
第9章 日本のバイオマーカー市場- 用途別の内訳
- 診断
- 医薬品の発見と開発
- パーソナライズ医療
- その他
第10章 日本のバイオマーカー市場- エンドユーザー別の内訳
- 製薬およびバイオテクノロジー企業
- 診断および研究ラボ
- 病院と専門クリニック
- その他
第11章 日本のバイオマーカー市場- 競合情勢
- 概要
- 市場構造
- 市場企業のポジショニング
- 主要成功戦略
- 競合ダッシュボード
- 企業評価象限
第12章 主要企業のプロファイル
第13章 日本のバイオマーカー市場- 業界分析
- 促進要因、抑制要因、機会
- ポーターのファイブフォース分析
- バリューチェーン分析
第14章 付録
Japan biomarkers market size reached USD 4.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.8 Billion by 2033, exhibiting a growth rate (CAGR) of 11.7% during 2025-2033. The market is being driven by several significant factors, including the increasing incidence of chronic illnesses, ongoing progress in biotechnology and genomics, the trend toward personalized medicine, continuous improvements in analytical technologies, and growing awareness among healthcare professionals and patients regarding the advantages of biomarkers.
Biomarkers are quantifiable signals originating from within the human body that offer vital insights into various biological functions and states. These indicators can encompass a diverse array of substances, ranging from proteins, genes, and hormones to physical attributes. Biomarkers hold a pivotal role in the domains of medical research, diagnosis, and treatment planning. They empower healthcare professionals and researchers to evaluate the presence or progression of diseases, assess the efficacy of therapeutic interventions, and anticipate an individual's predisposition to specific health conditions. In the context of market research and consulting services, a comprehensive grasp of biomarkers is indispensable as they inform decision-making processes within the healthcare and pharmaceutical sectors. This understanding plays a fundamental role in the development of innovative solutions and strategic approaches.
Japan Biomarkers Market Trends:
In the context of the Japan biomarkers market, the surge in chronic illnesses, encompassing conditions like cancer, cardiovascular disorders, and diabetes, stands as a pivotal growth driver. Biomarkers are instrumental in the early detection, ongoing monitoring, and formulation of individualized treatment approaches for these diseases. Japan's continuous strides in biotechnology and genomics contribute to the identification of novel biomarkers, extending their utility in areas such as diagnostics, drug development, and precision medicine. In pharmaceutical research within the Japanese market, biomarkers play an integral role by aiding in target identification, evaluating the efficacy of drug candidates, and conducting safety profiling. This expedites the drug development process, curtails expenses, and enhances the overall success rates of therapeutic interventions. The adoption of personalized medicine practices in Japan is reliant on biomarkers to customize treatment regimens according to the distinct profiles of patients, thereby augmenting treatment outcomes while minimizing adverse effects. Japan's aging population, like many other regions globally, significantly propels market growth, given the heightened susceptibility of elderly individuals to chronic ailments, underscoring the need for early detection and effective disease management facilitated by biomarkers. Furthermore, Japan's continuous enhancements in analytical technologies, encompassing genomics, proteomics, and imaging, enhance the precision and specificity of biomarker detection, further broadening their applications and fostering market expansion within the country.
Japan Biomarkers Market Segmentation:
Product Insights:
- Consumables
- Services
- Software
Type Insights:
- Efficacy Biomarkers
- Safety Biomarkers
- Validation Biomarkers
Disease Insights:
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Immunological Disorders
- Renal Disorders
- Others
Application Insights:
- Diagnostics
- Drug Discovery and Development
- Personalized Medicine
- Others
End User Insights:
- Pharmaceutical and Biotechnology Companies
- Diagnostic and Research Laboratories
- Hospitals and Specialty Clinics
- Others
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan biomarkers market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan biomarkers market?
- What is the breakup of the Japan biomarkers market on the basis of product?
- What is the breakup of the Japan biomarkers market on the basis of type?
- What is the breakup of the Japan biomarkers market on the basis of disease?
- What is the breakup of the Japan biomarkers market on the basis of application?
- What is the breakup of the Japan biomarkers market on the basis of end user?
- What are the various stages in the value chain of the Japan biomarkers market?
- What are the key driving factors and challenges in the Japan biomarkers?
- What is the structure of the Japan biomarkers market and who are the key players?
- What is the degree of competition in the Japan biomarkers market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Biomarkers Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Biomarkers Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan Biomarkers Market - Breakup by Product
- 6.1 Consumables
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
- 6.2 Services
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
- 6.3 Software
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
7 Japan Biomarkers Market - Breakup by Type
- 7.1 Efficacy Biomarkers
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
- 7.2 Safety Biomarkers
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
- 7.3 Validation Biomarkers
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
8 Japan Biomarkers Market - Breakup by Disease
- 8.1 Cancer
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
- 8.2 Cardiovascular Disorders
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
- 8.3 Neurological Disorders
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
- 8.4 Immunological Disorders
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
- 8.5 Renal Disorders
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2019-2024)
- 8.5.3 Market Forecast (2025-2033)
- 8.6 Others
- 8.6.1 Historical and Current Market Trends (2019-2024)
- 8.6.2 Market Forecast (2025-2033)
9 Japan Biomarkers Market - Breakup by Application
- 9.1 Diagnostics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
- 9.2 Drug Discovery and Development
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
- 9.3 Personalized Medicine
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
- 9.4 Others
- 9.4.1 Historical and Current Market Trends (2019-2024)
- 9.4.2 Market Forecast (2025-2033)
10 Japan Biomarkers Market - Breakup by End User
- 10.1 Pharmaceutical and Biotechnology Companies
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Forecast (2025-2033)
- 10.2 Diagnostic and Research Laboratories
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)
- 10.3 Hospitals and Specialty Clinics
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2019-2024)
- 10.3.3 Market Forecast (2025-2033)
- 10.4 Others
- 10.4.1 Historical and Current Market Trends (2019-2024)
- 10.4.2 Market Forecast (2025-2033)
11 Japan Biomarkers Market - Competitive Landscape
- 11.1 Overview
- 11.2 Market Structure
- 11.3 Market Player Positioning
- 11.4 Top Winning Strategies
- 11.5 Competitive Dashboard
- 11.6 Company Evaluation Quadrant
12 Profiles of Key Players
- 12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Product Portfolio
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
- 12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Product Portfolio
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
- 12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Product Portfolio
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
- 12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Product Portfolio
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
- 12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Product Portfolio
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events
13 Japan Biomarkers Market - Industry Analysis
- 13.1 Drivers, Restraints and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
- 13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
- 13.3 Value Chain Analysis
